✨ Unlock Data Exports And Disclosure Access.Start Your 30-Day Free Trial Today →

Shijiazhuang Yiling Pharmaceutical Co Ltd

Common Name
Shijiazhuang Yiling Pharmaceutical
Country
China (Mainland)
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Employees
11,343
Ticker
002603
Exchange
Shenzhen Stock Exchange
Description
Shijiazhuang Yiling Pharmaceutical Co., Ltd. is a prominent company in the pharmaceutical industry specializing in the research, development, production, and sale of traditional Chinese medicine (TCM)...

Shijiazhuang Yiling Pharmaceutical's Waste Data Preview

In 2023, Shijiazhuang Yiling Pharmaceutical conducted an environmental assessment and disclosed corporate waste management data in accordance with recognized sustainability reporting standards.The company provided a breakdown of its waste by type (hazardous vs non-hazardous) and treatment method (recovery vs disposal), enabling greater transparency into its waste handling and environmental practices.

Metric (tonnes)20232022
Total Waste Generated
15,375.8a
19,322.9a
Total Waste Recovered
N/AN/A
Total Hazardous Waste Generated
213.8a
284.9a
Non-Hazardous Waste Disposed
15,162a
19,038a
Usage Policy

You are welcome to quote or reference individual data points from this page, provided you include the following attribution with a visible, clickable link to this page: "Source: Tracenable, the global reference for ESG data"

Bulk collection, scraping, resale, or redistribution of data across multiple company profiles is not permitted without our prior written permission. For more information, see our General Terms and Conditions.

Access Datasets, Disclosures, and Sources
pro
Remove manual data sourcing from your workflow. Subscribe to Tracenable Pro to get credits for accessing and exporting datasets and disclosures across 8,500+ companies with 10+ years of historical coverage.
Download granular datasets (CSV/XLS)
Access underlying corporate disclosures (PDF)
Trace all values back to their original sources
Formats Included
Excel
CSV
Json
All data fully traceable to original sources
Used by 1,000+ teams in finance, climate, and research

Verified Sources Behind Shijiazhuang Yiling Pharmaceutical’s Waste Management Data

Every figure on this dashboard has a transparent audit trail. With Tracenable, each data point is traceable back to its original source, viewable directly inside our platform.

a. Shijiazhuang Yiling Pharmaceutical's ESG Report 2023

Insights into Shijiazhuang Yiling Pharmaceutical’s Generation of Hazardous and Non-Hazardous Waste

In 2023, Shijiazhuang Yiling Pharmaceutical generated a total of 15,376 metric tonnes of waste.a

Of this amount, 1.39% of Shijiazhuang Yiling Pharmaceutical's total waste generated of was classified as hazardous waste, characterized by properties such as toxicity, flammability, corrosiveness, or reactivity that may pose risks to human health, ecosystems, or the environment.98.61% was identified as non-hazardous waste, generally considered less harmful and subject to lighter regulatory controls.a

Shijiazhuang Yiling Pharmaceutical’s Hazardous vs Non-Hazardous Waste Over Time

2022202305 k10 k15 k20 ktonnes
  • Total Non-Hazardous Waste Generated
  • Total Hazardous Waste Generated

How Shijiazhuang Yiling Pharmaceutical reduced the environmental impact of its waste?

Since 2023, Shijiazhuang Yiling Pharmaceutical's total waste generation has decreased by 20.43%, suggesting improvements in operational efficiency or the early results of waste minimization strategies.a

Since 2023, Shijiazhuang Yiling Pharmaceutical's hazardous waste generation has decreased by 5.69%, suggesting a recent shift toward safer materials, improved waste handling protocols, or stronger compliance with environmental standards.a

Overall, Shijiazhuang Yiling Pharmaceutical has reduced both its total waste and hazardous waste in the last year, suggesting effective waste management practices and improved material sourcing.a

Want Full Access to Shijiazhuang Yiling Pharmaceutical's Waste Management Dataset?
Start 30-Day Free Trial